Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Prongay
Andrew Prongay
Merck & Co.
Boceprevir
Chemistry
Protease
Organic chemistry
Potency
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure‐Based Drug Design
2012
Srikanth Venkatraman
Andrew Prongay
George F. Njoroge
Show All
Source
Cite
Save
Citations (0)
P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile.
2010
Bioorganic & Medicinal Chemistry Letters
Latha G. Nair
Mousumi Sannigrahi
Stephane Bogen
Patrick Pinto
Kevin X. Chen
Andrew Prongay
Xiao Tong
Kang Cheng
Viyyoor Moopil Girijavallabhan
F. George Njoroge
Show All
Source
Cite
Save
Citations (13)
1